ANNA NEWCOMBE: Open Payments
NPI 1508806662 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 7 payments from 6 companies in 2025. Trend: 2023 $405 · 2024 $880 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $272 |
| Janssen Pharmaceuticals, Inc | 1 | $142 |
| Corcept Therapeutics | 1 | $120 |
| Alkermes, Inc. | 1 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $101 |
| Otsuka America Pharmaceutical, Inc. | 1 | $85 |
Products named: DEXCOM G7 GSS (161), SPRAVATO, Korlym, LYBALVI, Dexcom G6 Transmitter, JARDIANCE, REXULTI.
Industry payments across OK — which companies pay providers there.
